Biomarkers

Evaluating Biomarkers During Clinical Trials for Immunotherapies: A Case Study on the Pioneer Project

November 27, 2019

NASH Clinical Drug Development: Imaging the Liver and Beyond

October 22, 2019
Blogs

Six of the Latest NASH/NAFLD Webinars
Life Science News

Biomarkers and Clinical Risk Factors Combined for More Accurate Atrial Fibrillation Diagnosis

Expansion Cohorts in Early Development of Anticancer Agents

February 21, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 2

January 22, 2019

From Biomarkers to Companion Diagnostics: Advances in Immuno-Oncology Clinical Trial Assay Development – Broadcast 1

January 22, 2019

Ligand Binding Assays and Hybrid LC-MS Quantitation of Biotherapeutics and Biomarkers

December 03, 2018

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

October 22, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment – Broadcast 2

October 09, 2018

Identifying Spatial Expression Patterns in the Tumor Microenvironment – Broadcast 1

October 09, 2018
Life Science News

Here’s Why Brain Biomarkers of Alzheimer’s Don’t Always Lead to Dementia
Biotech News

New Method Collects Circulating Tumor Cells from Blood Samples to be Used in Liquid Biopsy

Current Regulatory Guidelines for Human Biospecimens & Patient Consent in Clinical Research

July 11, 2018

Immunoprecipitation of Disease-Associated Proteins for Alzheimer’s Research

March 08, 2018

Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants

March 07, 2018